share_log

JMP Securities Reiterates Market Outperform on Cellectis, Maintains $6 Price Target

JMP Securities Reiterates Market Outperform on Cellectis, Maintains $6 Price Target

JMP Securities重申Cellectis的市場表現跑贏大盤,維持6美元的目標股價
Benzinga ·  2023/11/01 12:58

JMP Securities analyst Silvan Tuerkcan reiterates Cellectis (NASDAQ:CLLS) with a Market Outperform and maintains $6 price target.

JMP Securities分析師Silvan Tuerkcan重申了Cellectis(納斯達克股票代碼:CLLS)的市場表現跑贏大盤,並維持6美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論